Cite
Radiolabeled CyclosaligenylMonophosphates of 5-Iodo-2â²-deoxyuridine,5-Iodo-3â²-fluoro-2â²,3â²-dideoxyuridine, and 3â²-Fluorothymidinefor Molecular Radiotherapy of Cancer: Synthesis and Biological Evaluation
MLA
Kortylewicz, Zbigniew P., et al. “Radiolabeled CyclosaligenylMonophosphates of 5-Iodo-2â²-Deoxyuridine,5-Iodo-3â²-Fluoro-2â²,3â²-Dideoxyuridine, and 3â²-Fluorothymidinefor Molecular Radiotherapy of Cancer: Synthesis and Biological Evaluation.” Journal of Medicinal Chemistry, vol. 55, no. 6, Mar. 2012, pp. 2649–71. EBSCOhost, https://doi.org/10.1021/jm201482p.
APA
Kortylewicz, Z. P., Kimura, Y., Inoue, K., Mack, E., & Baranowska-Kortylewicz, J. (2012). Radiolabeled CyclosaligenylMonophosphates of 5-Iodo-2â²-deoxyuridine,5-Iodo-3â²-fluoro-2â²,3â²-dideoxyuridine, and 3â²-Fluorothymidinefor Molecular Radiotherapy of Cancer: Synthesis and Biological Evaluation. Journal of Medicinal Chemistry, 55(6), 2649–2671. https://doi.org/10.1021/jm201482p
Chicago
Kortylewicz, Zbigniew P., Yu Kimura, Kotaro Inoue, Elizabeth Mack, and Janina Baranowska-Kortylewicz. 2012. “Radiolabeled CyclosaligenylMonophosphates of 5-Iodo-2â²-Deoxyuridine,5-Iodo-3â²-Fluoro-2â²,3â²-Dideoxyuridine, and 3â²-Fluorothymidinefor Molecular Radiotherapy of Cancer: Synthesis and Biological Evaluation.” Journal of Medicinal Chemistry 55 (6): 2649–71. doi:10.1021/jm201482p.